A comparison of anatomic and functional imaging in the assessment of clinical outcomes in patients with Ewing sarcoma has shown that FDG-PET, assessed by PERCIST criteria, was superior in predicting clinical benefits and identifying responses, according to a study published in the Journal of Clinical Oncology.
See more here.
Study mentioned:
Koshkin VS, Bolejack V, Schwartz LH, et al. Assessment of imaging modalities and response metrics in Ewing sarcoma: correlation with survival [published online August 29, 2016]. J Clin Oncol. doi:10.1200/JCO.2016.68.1858.
No comments:
Post a Comment